Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment
Open Access
- 26 February 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (5) , 1601
Abstract
The human immunodeficiency virus (HIV) infection continues to be a social and public health problem. Thanks to more and more effective antiretroviral therapy (ART), nowadays HIV-positive patients live longer, thus increasing their probability to acquire other diseases, malignancies primarily. Senescence along with immune-system impairment, HIV-related habits and other oncogenic virus co-infections increase the cancer risk of people living with HIV (PLWH); in the next future non-AIDS-defining cancers will prevail, lung cancer (LC) in particular. Tumor in PLWH might own peculiar predictive and/or prognostic features, and antineoplastic agents’ activity might be subverted by drug-drug interactions (DDIs) due to concurrent ART. Moreover, PLWH immune properties and comorbidities might influence both the response and tolerability of oncologic treatments. The therapeutic algorithm of LC, rapidly and continuously changed in the last years, should be fitted in the context of a special patient population like PLWH. This is quite challenging, also because HIV-positive patients have been often excluded from participation to clinical trials, so that levels of evidence about systemic treatments are lower than evidence in HIV-uninfected individuals. With this review, we depicted the epidemiology, pathogenesis, clinical-pathological characteristics and implications for LC care in PLWH, offering a valid focus about this topic to clinicians.Keywords
This publication has 93 references indexed in Scilit:
- Results of Initial Low-Dose Computed Tomographic Screening for Lung CancerNew England Journal of Medicine, 2013
- HIV as an independent risk factor for incident lung cancerAIDS, 2012
- Comment on ‘Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection’British Journal of Cancer, 2012
- Human Immunodeficiency Virus Infection as a Prognostic Factor in Surgical Patients With Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2012
- Lung Cancer in HIV InfectionClinical Lung Cancer, 2012
- Use of antineoplastic agents in patients with cancer who have HIV/AIDSThe Lancet Oncology, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Lung Cancer Incidence and Mortality Among HIV-Infected and HIV-Uninfected Injection Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adultsCochrane Database of Systematic Reviews, 2010
- A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009